31 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
to return for post-treatment follow-up or we may be unable to recruit suitable patients to participate in our clinical trials; our product candidates … . We will have to compete with other pharmaceutical and biotechnology companies to recruit, hire, train, and retain marketing and sales personnel
8-K
EX-10.1
t2x09ah6gr88r04in
30 May 23
Entry into a Material Definitive Agreement
7:30am
ARS
dm688et6v
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
i551fi
18 Apr 23
Preliminary proxy
7:59am
8-K
EX-99.1
p2zjeo
24 Feb 22
C4 Therapeutics Reports Full Year 2021 Financial Results and Recent Business Highlights
7:30am
424B4
k5019krg
21 Jun 21
Prospectus supplement with pricing info
8:08am